Zometa® is effective and well tolerated in the prevention of skeletal related events secondary to metastatic breast cancer treated with hormonal therapy
- 1 April 2001
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 37, S152
- https://doi.org/10.1016/s0959-8049(01)81045-5
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: